Skip to main content
. Author manuscript; available in PMC: 2014 Jan 31.
Published in final edited form as: Circulation. 2011 Jul 11;124(5):572–581. doi: 10.1161/CIRCULATIONAHA.111.021352

Figure 4.

Figure 4

DOX treatment reversed cardiomyopathy in V1A-TG mice. (A) Schematic diagram showing that at 3 weeks of age, V1A-TG mice were fed with DOX diets. (B) Assessment of cardiac function (Fractional Shortening %) at 24 weeks of age. #adjusted p<0.01 vs V1A-TG. (C) VW/BW ratio. #adjusted p<0.01 vs V1A-TG. (D) Schematic diagram showing that at 24 weeks of age, V1A-TG mice were fed with DOX diets for 4 weeks. (E) Assessment of cardiac function. #adjusted p<0.01 vs V1A-TG. (F) Assessment of VW/BW. #adjusted p<0.01 vs V1A-TG. Tables of median, IQR and P values are included in the Supplemental Section.